{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:09:21Z","timestamp":1793408961963,"version":"4.5.0"},"reference-count":55,"publisher":"SAGE Publications","issue":"7-8","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neurotrauma"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>Two blood-based brain biomarker tests such as the combination of glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 (GFAP+UCH-L1) or S100B have potential to reduce the need for head computed tomography (CT) scanning in patients with mild traumatic brain injury (mTBI). We assessed the clinical and economic impact of using GFAP+UCH-L1 versus CT scan and GFAP+UCH-L1 versus S100B to screen adults with suspected mTBI presenting to an emergency department (ED). A decision model was developed to estimate costs and health outcomes of GFAP+UCH-L1, CT scan, and S100B associated with these screening protocols. Model parameters were extracted from peer-reviewed articles, clinical guidelines, and expert opinion. Analysis was performed from a French health care system perspective (costs in 2020 euros). In the model, patients with a positive biomarker receive a CT scan to confirm the presence of intracranial lesions (ICLs). Depending on clinical state and biomarker and CT results, patients were discharged immediately, kept for observation in the ED, admitted for in-hospital stay and observation, or admitted for surgical management. Incorrect test results may lead to delayed treatment and poor outcomes or overtreatment. GFAP+UCH-L1 use was associated with an overall decrease in CT scans when compared with CT screening or S100B use (325.42 and 46.43 CTs per 1000 patients, respectively). The use of GFAP+UCH-L1 resulted in modest cost savings when compared with CT scanning and with S100B. In all cases, use of GFAP+UCH-L1 marginally improved quality-adjusted life-years (QALYs) and outcomes. Thus, screening with GFAP+UCH-L1 reduced the need for CT scans when compared with systematic CT scan screening or use of S100B while maintaining similar costs and health outcomes.<\/jats:p>","DOI":"10.1089\/neu.2022.0270","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T01:56:52Z","timestamp":1666317412000},"page":"706-719","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting"],"prefix":"10.1177","volume":"40","author":[{"given":"Louise","family":"Zimmer","sequence":"first","affiliation":[{"name":"bioM\u00e9rieux, Inc., Durham, North Carolina, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"McDade","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Research Triangle Park, North Carolina, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Beyhaghi","sequence":"additional","affiliation":[{"name":"bioM\u00e9rieux, Inc., Durham, North Carolina, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Purser","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Research Triangle Park, North Carolina, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Textoris","sequence":"additional","affiliation":[{"name":"bioM\u00e9rieux, SA, Marcy-l'\u00c9toile, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Krause","sequence":"additional","affiliation":[{"name":"bioM\u00e9rieux, SA, Marcy-l'\u00c9toile, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Blanc","sequence":"additional","affiliation":[{"name":"bioM\u00e9rieux, SA, Marcy-l'\u00c9toile, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Pavlov","sequence":"additional","affiliation":[{"name":"bioM\u00e9rieux, SA, Marcy-l'\u00c9toile, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Earnshaw","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Research Triangle Park, North Carolina, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuchi.2020.02.002"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2541081672"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00002-2"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/02699052.2019.1629022"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.16316"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.2217\/cnc-2015-0002"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-50"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0723-z"},{"key":"e_1_3_5_10_2","unstructured":"U.S. Food and Drug Administration. FDA Authorizes Marketing of First Blood Test to Aid in the Evaluation of Concussion in Adults. Silver Spring Maryland; 2018. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-marketing-first-blood-test-aid-evaluation-concussion-adults#:\u223c:text=The%20FDA%20reviewed%20and%20authorized of%20its%20Breakthrough%20Devices%20Program [Last accessed: May 18 2022]."},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2018.6020"},{"key":"e_1_3_5_12_2","unstructured":"U.S. Food and Drug Administration. Abbott Earns FDA OK for Handheld Concussion Blood Test. Silver Spring Maryland; 2021. Available from: https:\/\/www.fdanews.com\/articles\/200829-abbott-earns-fda-ok-for-handheld-concussion-blood-test [Last accessed: April 11 2022]."},{"key":"e_1_3_5_13_2","unstructured":"Abbott. Abbott Receives CE Mark for First Widely Available Lab-Based Blood Test for Traumatic Brain Injury Increasing Access to Concussion Evaluation. 2021. Available from: https:\/\/www.abbott.co.uk\/media-center\/news\/abbott-receives-CE-Mark-for-first-widely-available-lab-based-blood-test-for-traumatic-brain-injury-increasing-access-to-concussion-evaluation.html [Last accessed: April 21 2022]."},{"key":"e_1_3_5_14_2","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). Guide methodologique. choix m\u00e9thodologiques pour l'\u00e9valuation de l'efficience \u00e0 la HAS version soumise \u00e0 la consultation publique. April 6 2020. Available from: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2020-11\/methodological_guidance_2020_-choices_in_methods_for_economic_evaluation.pdf [Last accessed: July 12 2022]."},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30231-X"},{"key":"e_1_3_5_16_2","unstructured":"Banyan Biomarkers. Banyan BTI\u2122 Brain Trauma Indicator Package Insert. 2019. Available from: http:\/\/banyanbio.com\/assets\/files\/BanyanBTI_IFU_700027_v1.pdf [Last accessed: February 22 2021]."},{"key":"e_1_3_5_17_2","unstructured":"Hoffmann-La Roche Ltd. Elecsys\u00ae S100. Product Characteristics. October 9 2019. Available from: https:\/\/diagnostics.roche.com\/ch\/de\/products\/params\/elecsys-s100.html [Last accessed: September 10 2019]."},{"key":"e_1_3_5_18_2","unstructured":"Jehl\u00e9 E Ray P Tazarourte K et al. Int\u00e9r\u00eat du dosage s\u00e9rique de la prot\u00e9ine S100B dans la prise en charge du traumatisme cr\u00e2nien l\u00e9ger. Annales fran\u00e7aises de m\u00e9decine d'urgence 2014;4(3)."},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-6-200703200-00004"},{"key":"e_1_3_5_20_2","unstructured":"U.S. Food and Drug Administration. Evaluation of Automatic Class III Designation for Banyan Brain Trauma Indicator Decision Memorandum. Silver Spring MD; 2018. Available from: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/DEN170045.pdf [Last accessed: July 26 2022]."},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14366"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.1302"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2017.5182"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta15270"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000172967"},{"key":"e_1_3_5_26_2","unstructured":"Institut National d'Edudes Demographiques. Provisional Data at the End of December 2018. Life Table 2015\u20132017. 2019. Available from: https:\/\/www.ined.fr\/en\/everything_about_population\/data\/france\/deaths-causes-mortality\/mortality-tables\/#r191 [Last accessed: October 24 2019]."},{"key":"e_1_3_5_27_2","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1016\/j.respe.2018.05.273","article-title":"Epidemiology of traumatic brain injuries based on hospital reports in mainland France","volume":"66","author":"Paget L-M","year":"2018","unstructured":"Paget L-M, , Th\u00e9lot B, , P\u00e9drono G. Epidemiology of traumatic brain injuries based on hospital reports in mainland France. Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique, 2018; 66:S339.","journal-title":"Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2020.02.006"},{"key":"e_1_3_5_29_2","article-title":"Association of emergency department waiting times with patient experience in admitted and discharged patients","volume":"8","author":"Nyce A","year":"2021","unstructured":"Nyce A, , Gandhi S, , Freeze B, et al. Association of emergency department waiting times with patient experience in admitted and discharged patients. J Patient Exp, 2021; 8:23743735211011404.","journal-title":"J Patient Exp"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2009.0928"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109072"},{"key":"e_1_3_5_32_2","doi-asserted-by":"crossref","unstructured":"Lagares A Casta\u00f1o-Leon AM Richard M et al. Variability in the indication of brain CT scan after mild traumatic brain injury. A transnational survey. Eur J Trauma Emerg Surg 2022; doi: 10.1007\/s00068-022-01902-5 [Online ahead of print].","DOI":"10.1007\/s00068-022-01902-5"},{"key":"e_1_3_5_33_2","unstructured":"Gil-Jardin\u00e9 C Payen JF Bernard R et al. Soci\u00e9t\u00e9 fran\u00e7aise de m\u00e9decine d'urgence (SFMU)Recommandations de pratiques professionnelles. Prise en charge des patients presentant un traumatisme cr\u00e2nien leger de l'adulte. 2022. Available from: https:\/\/www.sfmu.org\/upload\/consensus\/RPP-TCL-2022.pdf [Last accessed: October 10 2022]."},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/acem.13061"},{"issue":"11","key":"e_1_3_5_35_2","first-page":"483","article-title":"CT overuse for mild traumatic brain injury","volume":"38","author":"Melnick ER","year":"2012","unstructured":"Melnick ER, , Szlezak CM, , Bentley SK, et al. CT overuse for mild traumatic brain injury. Jt Comm J Qual Patient Saf, 2012; 38(11):483\u2013489.","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/acem.13756"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2018.6061"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2009.1011"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2006.08.059"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.135178"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-6723.2007.00969.x"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0b013e31819a8966"},{"key":"e_1_3_5_43_2","unstructured":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9. Le r\u00e9f\u00e9rentiel des actes innovants hors nomenclature de biologie et d\u2019anatomopathologie (RIHN). 2019. Available from: https:\/\/solidarites-sante.gouv.fr\/systeme-de-sante-et-medico-social\/recherche-et-innovation\/rihn [Last accessed: January 16 2020]."},{"key":"e_1_3_5_44_2","unstructured":"Agence technique de l'information sur l'hospitalisation. Tarifs MCO et HAD. 2020. Available from: https:\/\/www.atih.sante.fr\/tarifs-mco-et-had [Last accessed: April 22 2020]."},{"key":"e_1_3_5_45_2","unstructured":"Securite Sociale l'Assurance Maladie. Landmarks n\u00b050. The activity of liveral doctors through CCAM: Actes techniques m\u00e9dicaux: quantit\u00e9 et montants rembours\u00e9s correspondants en 2016. 2018. Available from: https:\/\/www.ameli.fr\/sites\/default\/files\/2018-07_actes-ccam-2016_points-de-repere-50_assurance-maladie.pdf [Last accessed: April 7 2022]."},{"key":"e_1_3_5_46_2","unstructured":"Organisation for Economic Co-operation and Development. Purchasing power parities (PPP). 2020. Available from: https:\/\/data.oecd.org\/conversion\/purchasing-power-parities-ppp.htm [Last accessed: April 22 2020]."},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13492"},{"key":"e_1_3_5_48_2","unstructured":"Securite Sociale l'Assurance Maladie. Les tarifs applicables en m\u00e9tropole dans les d\u00e9partements d'outre-mer et \u00e0 Mayotte. 2020. Available from: https:\/\/www.ameli.fr\/infirmier\/exercice-liberal\/facturation-remuneration\/tarifs-conventionnels\/tarifs [Last accessed: April 22 2020]."},{"key":"e_1_3_5_49_2","unstructured":"Securite Sociale l'Assurance Maladie. Classification Commune des Actes Medicaux. 2020. Available from: https:\/\/www.ameli.fr\/accueil-de-la-ccam\/trouver-un-acte\/fiche-abregee.php?code=ABCA001 [Last accessed: April 22 2020]."},{"key":"e_1_3_5_50_2","unstructured":"Institut National de la Statistique et des \u00c9tudes \u00c9conomiques. Harmonised index of consumer prices. 2020. Available from: https:\/\/www.insee.fr\/en\/statistiques\/series\/103157760?COICOP2016=2319377 [Last accessed: April 22 2020]."},{"key":"e_1_3_5_51_2","unstructured":"COS Paris Healthcare. Cancer statistics in France: the key facts and figures. 2019. Available from: https:\/\/www.cos-eu.com\/en\/find-cancer-france-cos\/cancer-statistics-france\/ [Last accessed: December 11 2019]."},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61680-8"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199915040-00004"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9801800401"},{"key":"e_1_3_5_55_2","doi-asserted-by":"crossref","unstructured":"Dijkers MP. Quality of life after traumatic brain injury: a review of research approaches and findings. Arch Phys Med Rehabil 2004;85:21\u201335.","DOI":"10.1016\/j.apmr.2003.08.119"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2011.2222"}],"container-title":["Journal of Neurotrauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/neu.2022.0270","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/neu.2022.0270","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/neu.2022.0270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:41:20Z","timestamp":1777675280000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/neu.2022.0270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":55,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1089\/neu.2022.0270"],"URL":"https:\/\/doi.org\/10.1089\/neu.2022.0270","relation":{},"ISSN":["0897-7151","1557-9042"],"issn-type":[{"value":"0897-7151","type":"print"},{"value":"1557-9042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]}}}